lung cancer

Examining the Effect of Teleconferences on Oncology Phase 1 Trials.

Published August 1, 2013

Examining the effect of teleconferences on oncology phase 1 trials.

J Cancer. 2013; 4(6): 464-7
McKane A, Sima C, Fleck S, Weiss GJ

Objective: Phase 1 clinical trials are the first stage of clinical development of an investigational agent.… Continue reading →

Multidrug-Resistant Tuberculosis in Panama Is Driven by Clonal Expansion of an MDR-TB Strain Related to the KZN XDR-TB Strain From South Africa.

Published July 27, 2013

Multidrug-resistant tuberculosis in Panama is driven by clonal expansion of an MDR-TB strain related to the KZN XDR-TB strain from South Africa.

J Clin Microbiol. 2013 Jul 24;
Lanzas F, Karakousis PC, Sacchettini JC, Ioerger TR

Multidrug-resistant tuberculosis (MDR-TB)… Continue reading →

Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination.

Published July 16, 2013

Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination.

PLoS Med. 2013 Jun; 10(6): e1001467
Sturrock HJ, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, Gosling RD

Hugh Sturrock and colleagues discuss the role of active… Continue reading →

Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations.

Published July 13, 2013

Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations.

Front Oncol. 2013; 3: 176
Nieder C, Pawinski A, Andratschke NH

The important role of combined chemoradiation for several groups of… Continue reading →

Firearm Possession Among Adolescents Presenting to an Urban Emergency Department for Assault.

Published July 10, 2013

Firearm Possession Among Adolescents Presenting to an Urban Emergency Department for Assault.

Pediatrics. 2013 Jul 8;
Carter PM, Walton MA, Newton MF, Clery M, Whiteside LK, Zimmerman MA, Cunningham RM

BACKGROUND AND OBJECTIVES:Firearm violence is a leading cause of… Continue reading →

Gene and microRNA Expression Reveals Sensitivity to Paclitaxel in Laryngeal Cancer Cell Line.

Published July 5, 2013

Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.

Int J Clin Exp Pathol. 2013; 6(7): 1351-61
Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, Wang BX, Dong P

Paclitaxel is a widely… Continue reading →

Crofelemer: A Review of Its Use in the Management of Non-Infectious Diarrhoea in Adult Patients With HIV/AIDS on Antiretroviral Therapy.

Published June 29, 2013

Crofelemer: A Review of its Use in the Management of Non-Infectious Diarrhoea in Adult Patients with HIV/AIDS on Antiretroviral Therapy.

Drugs. 2013 Jun 27;
Frampton JE

Crofelemer (Fulyzaq™) is a botanical drug substance (oligomeric proanthocyanidin) extracted from the stem… Continue reading →

DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation.

Published June 28, 2013

DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation.

PLoS One. 2013; 8(6): e67782
Guha M, Castellanos-Rizaldos E, Makrigiorgos GM

Non-small cell lung cancer (NSCLC) patients treated with small molecule EGFR inhibitors, such as gefitinib, frequently develop… Continue reading →

IL-23R Is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer.

Published June 28, 2013

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer.

Front Oncol. 2013; 3: 162
Baird AM, Dockry E, Daly A, Stack E, Doherty DG, O’Byrne KJ, Gray SG

The Interleukin-23 (IL-23)/IL-23R signaling axis is an… Continue reading →

Crizotinib in the Treatment of Non-Small-Cell Lung Carcinoma.

Published June 23, 2013

Crizotinib in the treatment of non-small-cell lung carcinoma.

Contemp Oncol (Pozn). 2012; 16(6): 480-484
P?u?a?ski A, Piórek A, Krzakowski M

Recent studies have demonstrated the benefit of EGFR tyrosine kinase inhibitors in the treatment of advanced non-small-cell lung cancer… Continue reading →